APPLICATIONS OF PHARMACOGENETICS TO DRUG DEVELOPMENT: THE GLAXO WELLCOME EXPERIENCE1 *

Author： ARLEDGE TERESA FREEMAN ANDREW ARBUCKLE JULIAN MOSTELLER MICHAEL MANASCO PENELOPE

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.32, Iss.3-4, 2000-10, pp. : 387-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pipeline Pharmacogenetics: A Novel Approach to Integrating Pharmacogenetics into Drug Development

Current Pharmaceutical Design, Vol. 15, Iss. 32, 2009-11 ,pp. : 3754-3763

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory aspects of integration of pharmacogenetics into drug development

By R S.R.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 67-69

Adis International

Access to resources Recommend Favorite

The antiviral valaciclovir [`Valtrex'; Glaxo Wellcome] has been launched in Japan

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Glaxo Wellcome: top of the class for small molecules; where in genomics?

By Thomas S. Burke J.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 2, 1998-02 ,pp. : 103-109

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics: pharmacogenie or pharmacogenerality in future drug discovery and development?

By D D.A.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 54-56

Adis International

Access to resources Recommend Favorite